Thai HIV vaccine trial prompts angry exchanges.
Nelson
Kathleen
K
D016915:AIDS Vaccines / Q000096:biosynthesis / Q000627:therapeutic use*; D028121:Canarypox virus / Q000276:immunology; D017326:Clinical Trials, Phase III as Topic / Q000592:standards*; D034462:Dissent and Disputes; D006078:Government Programs / Q000592:standards; D015699:HIV Envelope Protein gp120 / Q000096:biosynthesis / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D015497:HIV-1; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000592:standards; D011994:Recombinant Proteins / Q000096:biosynthesis; D012109:Research Support as Topic / Q000592:standards; D013785:Thailand; D014481:United States
D016915:AIDS Vaccines; D015699:HIV Envelope Protein gp120; D011994:Recombinant Proteins